Table 1.
Cohort |
χ2 (DF) | P value | |||
---|---|---|---|---|---|
Total (n = 910) | Pre-COVID (n = 455) | COVID (n = 455) | |||
n (%) | n (%) | n (%) | |||
Race/Ethnicity | |||||
Black | 261 (28.7) | 130 (28.6) | 131 (28.8) | 0.01 (1) | 0.94 |
Latino | 126 (13.8) | 63 (13.8) | 63 (13.8) | 0.00 (1) | 1.00 |
White | 439 (48.2) | 220 (48.4) | 219 (48.1) | 0.00 (1) | 0.95 |
Other | 84 (9.2) | 42 (9.2) | 42 (9.2) | 0.00 (1) | 1.00 |
Region | |||||
Northeast | 216 (23.7) | 108 (23.7) | 108 (23.7) | 0.00 (1) | 1.00 |
Midwest | 166 (18.2) | 83 (18.2) | 83 (18.2) | 0.00 (1) | 1.00 |
South | 349 (38.4) | 177 (38.9) | 172 (37.8) | 0.12 (1) | 0.73 |
West | 174 (19.1) | 87 (19.1) | 87 (19.1) | 0.00 (1) | 1.00 |
Sexual Orientation | |||||
Gay | 701 (77.0) | 353 (77.6) | 348 (76.5) | 0.16 (1) | 0.69 |
Bisexual | 165 (18.1) | 80 (17.6) | 85 (18.7) | 0.19 (1) | 0.67 |
Other | 44 (4.8) | 22 (4.8) | 22 (4.8) | 0.00 (1) | 1.00 |
PrEP, HIV | |||||
Positive | 221 (24.3) | 108 (23.7) | 113 (24.8) | 0.15 (1) | 0.70 |
Negative, no PrEP Rx | 505 (55.5) | 255 (56.0) | 250 (54.9) | 0.11 (1) | 0.74 |
Negative, PrEP Rx | 184 (20.2) | 92 (20.2) | 92 (20.2) | 0.00 (1) | 1.00 |
Relationship status | |||||
Single | 703 (77.3) | 351 (77.1) | 352 (77.4) | 0.01 (1) | 0.98 |
Partnered | 207 (22.7) | 104 (22.9) | 103 (22.6) | 0.01 (1) | 0.98 |
Drug Use | |||||
Marijuana | 365 (40.1) | 208 (45.7) | 157 (34.5) | 11.90 (1) | <0.01 |
Other illegal Drugs | 154 (16.9) | 104 (22.9) | 50 (11.0) | 22.79 (1) | <0.001 |
Meth | 87 (9.6) | 54 (11.9) | 33 (7.3) | 5.61(1) | 0.02 |
MDMA, GHB, K | 78 (8.6) | 61 (13.4) | 17 (3.7) | 27.15(1) | < 0.001 |
Cocaine, Crack | 67 (7.4) | 48 (10.5) | 19 (4.2) | 13.55 (1) | < 0.001 |
CAS with casual partners | 446 (49.0) | 326 (71.6) | 120 (26.4) | 186.61 (1) | < 0.001 |
M (SD) | M (SD) | M (SD) | Test Statistic | ||
Age | 40.53 (13.41) | 40.08 (13.40) | 40.97 (13.42) | t(908) = -0.99 | 0.32 |
Casual sex partners, per month | 1.56 (3.14) | 1.59 (3.07) | 1.53 (3.22) | Waldχ2(1) = 0.25 | 0.62 |